GeneDx Holdings
231 hedge funds and large institutions have $2.91B invested in GeneDx Holdings in 2025 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 87 increasing their positions, 63 reducing their positions, and 48 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 63
16% more capital invested
Capital invested by funds: $2.52B → $2.91B (+$392M)
15% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 48
9.18% more ownership
Funds ownership: 101.24% → 110.41% (+9.2%)
3% more funds holding
Funds holding: 225 → 231 (+6)
8% less funds holding in top 10
Funds holding in top 10: 12 → 11 (-1)
16% less call options, than puts
Call options by funds: $210M | Put options by funds: $252M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$93.3M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$74.5M |
| 3 |
CM
Corvex Management
New York
|
+$45.9M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$41.9M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
+$34.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$207M |
| 2 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$34.2M |
| 3 |
D.E. Shaw & Co
New York
|
-$30.7M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$23.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$18.4M |
WGS Hedge Fund Activity: Q2 2025 in Review
231 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q2 2025, worth a combined $2.91B — up 16% from $2.52B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new WGS positions and 48 closed out — a net gain of 7 holders — while 87 added to existing stakes and 63 trimmed.
The largest buyer was Pentwater Capital Management, adding an estimated $93.3M. The largest seller was Fidelity Investments, cutting an estimated $207M.
- 231 institutional investors held GeneDx Holdings (WGS) as of Q2 2025, up from 225 in Q1 2025.
- Funds reported $2.91B of GeneDx Holdings stock for Q2 2025, up 16% quarter-over-quarter.
- 55 funds opened new GeneDx Holdings positions in Q2 2025 and 48 closed out, a net change of +7 holders.
- The largest GeneDx Holdings buyer in Q2 2025 was Pentwater Capital Management, an estimated $93.3M added.
- The largest GeneDx Holdings seller in Q2 2025 was Fidelity Investments, an estimated $207M sold.
Based on aggregated 13F filings for Q2 2025.